Page results
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
This page provides information about anaesthesia for children having proton beam therapy.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
This page provides general information about extreme lateral lumbar fusion and decompression (XLIF®).
-
Organisations and services offering financial advice to people affected by cancer and blood conditions, and their familes and carers.
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
Neurosurgery is a treatment option for some people with epilepsy.
-
This page has information on how to treat iron overload with Desferrioxamine. It has information on how the medicine is delivered and how you can do it at home.
-
Information about the use of deferasirox iron chelation treatment for iron overload.
File results
-
FOI/2024/0687 - Newly diagnosed patients with AML starting first line treatment - February-July 2024
-
FOI/2024/0690 - Mechanical transport ventilation/ ventway sparrow transport ventilator
-
FOI/2024/0691 - Information distributed to pregnant/ post-partum women for infant feeding
-
FOI/2024/0692 - Integrated Care Board (ICB) expenditure sign-off process 2023/24
-
FOI/2024/0693 - Patients overhead or ceiling track hoists portable/ mobile hoists installed
-
FOI/2024/0695 - Air filtration used/ air exchange rate across Trust
-
FOI/2024/0696 - Various IT systems used at Trust
-
FOI/2024/0697 - Autism spectrum disorder (ASD)/ attention deficit hyperactivity disorder (ADHD) and mental health services
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed